I

Isu Abxis Co Ltd
KOSDAQ:086890

Watchlist Manager
Isu Abxis Co Ltd
KOSDAQ:086890
Watchlist
Price: 5 200 KRW -1.89% Market Closed
Market Cap: 206.4B KRW

Gross Margin
Isu Abxis Co Ltd

70%
Current
56%
Average
63.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
70%
=
Gross Profit
41.6B
/
Revenue
59.4B

Gross Margin Across Competitors

No Stocks Found

Isu Abxis Co Ltd
Glance View

Market Cap
192.7B KRW
Industry
Biotechnology

ISU Abxis Co., Ltd. engages in the provision of pharmaceutical products. The company is headquartered in Seongnam, Gyeonggi-Do and currently employs 143 full-time employees. The company went IPO on 2009-02-03. The firm operates its business under two divisions: antibody therapeutics business division and diagnostic business division. Its antibody therapeutics business division engages in the development of Cloticab, which is a monoclonal therapeutic antibody for thrombus. Its diagnostic business division engages in the provision of genetic testing services and chemotherapy response assay services for cancer examination.

Intrinsic Value
6 490.52 KRW
Undervaluation 20%
Intrinsic Value
Price
I
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
70%
=
Gross Profit
41.6B
/
Revenue
59.4B
What is the Gross Margin of Isu Abxis Co Ltd?

Based on Isu Abxis Co Ltd's most recent financial statements, the company has Gross Margin of 70%.

Back to Top